Phase 1
- Phase IA Phase 1 Study of ASP3082 in Participants With Previously Treated Locally Advanced or Metastatic Solid Tumor Malignancies With KRAS G12D MutationPrincipal Investigator: Patricia LoRusso
- Phase IPhase Ib/II Study of ZEN003694 and Entinostat in Advanced and Refractory Solid Tumors and LymphomasPrincipal Investigator: Patricia LoRusso